In preparation for the development of a new line of products, a regulatory affairs professional is asked to prepare a short presentation for senior management. Which of the following topics is MOST important to cover?

• A.Capacity of the manufacturing facilities to fully produce the new product
• B.Regulatory requirements for labeling and packaging
• C.Previous actions taken by regulatory authorities on similar products
• D.Potential clinical sites for the Phase III clinical trial

Comment: *

Name: *

Email: *

Verification: *

According to ICH, which of the following components of study information is NOT required in a clinical study report?

• A.Randomization scheme and codes
• B.Protocol and protocol amendments
• C.List of lECs or lRBs
• D.Detailed CV of all investigators

Comment: *

Name: *

Email: *

Verification: *

During a regulatory authority inspection of a manufacturing site, the inspector observes that one of the medicinal products manufactured at the site is not GMP compliant. The product
Is distributed globally.
Which of the following is the most appropriate action to take FIRST?

• A.Withdraw the affected product from the markets.
• B.Send a "Dear Dr." letter to customers.
• C.Assess the potential safety risk.
• D.Notify the global regulatory authorities.

Comment: *

Name: *

Email: *

Verification: *

During a routine review of promotional materials for a product, a regulatory affairs professional discovers an off-label indication. Which of the following would be the FIRST follow-up action for the regulatory affairs professional to take?

• A.Communicate with the sales department to stop using the promotional materials.
• B.Contact the marketing department to recall the product.
• C.Allow doctors to use the product for the off-label indication.
• D.Request that doctors stop using the product for the off-label indication.

Comment: *

Name: *

Email: *

Verification: *

A regulation change is imminent and may require further non-clinical testing on a product currently in Phase III clinical trials. What is the most appropriate action to take FIRST?

• A.Obtain a copy of the proposed regulation and analyze the impact.
• B.Inform the company's senior management and arrange an emergency meeting
• C.Consult with the company's legal department regarding options.
• D.Arrange for additional testing of the product at the testing facility.

Comment: *

Name: *

Email: *

Verification: *